These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1356619

  • 1. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.
    Friche E, Danks MK, Beck WT.
    Cancer Res; 1992 Oct 15; 52(20):5701-6. PubMed ID: 1356619
    [Abstract] [Full Text] [Related]

  • 2. Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells.
    Friche E, Danks MK, Schmidt CA, Beck WT.
    Cancer Res; 1991 Aug 15; 51(16):4213-8. PubMed ID: 1678312
    [Abstract] [Full Text] [Related]

  • 3. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E, Demant EJ, Sehested M, Nissen NI.
    Br J Cancer; 1993 Feb 15; 67(2):226-31. PubMed ID: 8094288
    [Abstract] [Full Text] [Related]

  • 4. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M, Skovsgaard T, Jensen PB, Demant EJ, Friche E, Bindslev N.
    Br J Cancer; 1990 Jul 15; 62(1):37-41. PubMed ID: 1975202
    [Abstract] [Full Text] [Related]

  • 5. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E, Jensen PB, Sehested M, Demant EJ, Nissen NN.
    Cancer Commun; 1990 Jul 15; 2(9):297-303. PubMed ID: 1976341
    [Abstract] [Full Text] [Related]

  • 6. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T.
    Cancer Chemother Pharmacol; 2002 Jun 15; 49(6):453-60. PubMed ID: 12107549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D, Maare C, Eriksen J, Litman T, Skovsgaard T.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1050-7. PubMed ID: 11704330
    [Abstract] [Full Text] [Related]

  • 12. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
    Nielsen D, Maare C, Skovsgaard T.
    Biochem Pharmacol; 1995 Aug 08; 50(4):443-50. PubMed ID: 7646548
    [Abstract] [Full Text] [Related]

  • 13. Relationship of VP-16 to the classical multidrug resistance phenotype.
    Sehested M, Friche E, Jensen PB, Demant EJ.
    Cancer Res; 1992 May 15; 52(10):2874-9. PubMed ID: 1581902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.
    Demant EJ, Sehested M, Jensen PB.
    Biochim Biophys Acta; 1990 Nov 12; 1055(2):117-25. PubMed ID: 2242381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells.
    Sehested M, Skovsgaard T, Roed H.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3305-10. PubMed ID: 3401258
    [Abstract] [Full Text] [Related]

  • 19. 31P and 13C NMR spectroscopic study of wild type and multidrug resistant Ehrlich ascites tumor cells.
    Rasmussen J, Hansen LL, Friche E, Jaroszewski JW.
    Oncol Res; 1993 Sep 01; 5(3):119-26. PubMed ID: 8260748
    [Abstract] [Full Text] [Related]

  • 20. Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II.
    Jensen PB, Jensen PS, Demant EJ, Friche E, Sørensen BS, Sehested M, Wassermann K, Vindeløv L, Westergaard O, Hansen HH.
    Cancer Res; 1991 Oct 01; 51(19):5093-9. PubMed ID: 1655244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.